114 related articles for article (PubMed ID: 12605170)
1. [Edema of the eyelids caused by sirolimus in renal transplant recipients].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):83. PubMed ID: 12605170
[No Abstract] [Full Text] [Related]
2. Sirolimus and angiotensin-converting enzyme inhibitors together induce tongue oedema in renal transplant recipients.
Stallone G; Infante B; Di Paolo S; Schena A; Grandaliano G; Gesualdo L; Schena FP
Nephrol Dial Transplant; 2004 Nov; 19(11):2906-8. PubMed ID: 15496567
[No Abstract] [Full Text] [Related]
3. Sirolimus-associated eyelid edema in kidney transplant recipients.
Mohaupt MG; Vogt B; Frey FJ
Transplantation; 2001 Jul; 72(1):162-4. PubMed ID: 11468553
[TBL] [Abstract][Full Text] [Related]
4. Subclinical rejection and sirolimus associated edema in renal allograft recipients.
Rico J; Cruzado JM; Bestard O; Duarte V; Rama I; Gomà M; Torras J; Grinyó JM
Transpl Int; 2007 Jul; 20(7):636-9. PubMed ID: 17442067
[No Abstract] [Full Text] [Related]
5. Immunosuppressant-Related Lower Eyelid Edema in Transplant Patients.
Logan SA; Thyparampil PJ; Yen MT
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S58-S60. PubMed ID: 26730861
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous effects of sirolimus in renal transplant recipients.
Warino L; Libecco J
J Drugs Dermatol; 2006 Mar; 5(3):273-4. PubMed ID: 16573262
[TBL] [Abstract][Full Text] [Related]
7. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients.
Morelon E; Stern M; Kreis H
N Engl J Med; 2000 Jul; 343(3):225-6. PubMed ID: 10928875
[No Abstract] [Full Text] [Related]
8. Late introduction of sirolimus induces anemia in renal transplant recipients.
Thaunat O; Beaumont C; Lechaton S; Kreis H; Morelon E
Transplantation; 2007 May; 83(9):1283; author reply 1284. PubMed ID: 17496550
[No Abstract] [Full Text] [Related]
9. Sirolimus: defining nephrotoxicity in the renal transplant recipient.
Tomlanovich SJ; Vincenti F
Clin J Am Soc Nephrol; 2007 Mar; 2(2):198-9. PubMed ID: 17699406
[No Abstract] [Full Text] [Related]
10. Side effects of sirolimus.
Merkel S; Mogilevskaja N; Mengel M; Haller H; Schwarz A
Transplant Proc; 2006 Apr; 38(3):714-5. PubMed ID: 16647452
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium xenopi pulmonary infection in two renal transplant recipients under sirolimus therapy.
Thaunat O; Morelon E; Stern M; Buffet P; Offredo C; Mamzer-Bruneel MF; Kreis H
Transpl Infect Dis; 2004 Dec; 6(4):179-82. PubMed ID: 15762936
[TBL] [Abstract][Full Text] [Related]
12. Angioedema in renal transplant recipients on sirolimus.
Mahé E; Morelon E; Lechaton S; Kreis H; de Prost Y; Bodemer C
Dermatology; 2007; 214(3):205-9. PubMed ID: 17377381
[TBL] [Abstract][Full Text] [Related]
13. Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic, and pathogenic aspects.
Mahé E; Morelon E; Lechaton S; Drappier JC; de Prost Y; Kreis H; Bodemer C
J Am Acad Dermatol; 2006 Jul; 55(1):139-42. PubMed ID: 16781309
[TBL] [Abstract][Full Text] [Related]
14. Cardiac tamponade in a pediatric renal transplant recipient on sirolimus therapy.
Truong U; Moon-Grady AJ; Butani L
Pediatr Transplant; 2005 Aug; 9(4):541-4. PubMed ID: 16048611
[TBL] [Abstract][Full Text] [Related]
15. Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients.
Dansirikul C; Duffull SB; Morris RG; Tett SE
Br J Clin Pharmacol; 2005 Nov; 60(5):560-5. PubMed ID: 16236047
[TBL] [Abstract][Full Text] [Related]
16. Generalized lymphedema in a sirolimus-treated renal transplant patient.
De Bartolomeis C; Collini A; Rumberger B; Barni R; Ruggieri G; Bernini M; Carmellini M
Clin Transplant; 2008; 22(2):254-7. PubMed ID: 18339149
[TBL] [Abstract][Full Text] [Related]
17. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
[TBL] [Abstract][Full Text] [Related]
18. Sympathetic dystrophy associated with sirolimus therapy.
Molina MG; Diekmann F; Burgos D; Cabello M; Lopez V; Oppenheimer F; Navarro A; Campistol J
Transplantation; 2008 Jan; 85(2):290-2. PubMed ID: 18212635
[TBL] [Abstract][Full Text] [Related]
19. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent.
Firpi RJ; Tran TT; Flores P; Nissen N; Colquhoun S; Shackleton C; Martin P; Vierling JM; Poordad FF
Aliment Pharmacol Ther; 2004 May; 19(9):1033-9. PubMed ID: 15113371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
